x
CME-Tagline

Are We Ready for Psychedelics?

CMEO Podcast

Premiere Date: Friday, May 8, 2020

This activity offers CE credit for:

  1. Physicians (CME)
  2. Pharmacists (ACPE)
  3. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Saturday, May 8, 2021

Faculty


Paul Summergrad, MD Paul Summergrad, MD 
Dr. Frances S. Arkin Professor and Chairman
Department of Psychiatry
Professor of Medicine
Tufts University School of Medicine
Psychiatrist-in-Chief
Tufts Medical Center
Boston, MA

Statement of Need

A variety of psychedelic agents have been studied for the clinical purpose of treating psychiatric disorders, such as psilocybin for mood and anxiety disorders and 3,4-methylenedioxy-methamphetamine (MDMA) for PTSD. While they were effective in reducing symptoms, with many participants rating their experiences as among the most profound and meaningful of their lives, neuroimaging studies with these and other psychedelic agents are still in their early stages. Given the strength of these findings, more extensive studies are called for, as are studies in more diverse populations, with additional thought given as to how to deal with the unique legal, ethical, and regulatory issues surrounding the clinical use of these agents.

In this CMEOCast podcast, expert faculty discuss the complex history and focus on the preliminary clinical data that support the use of psychedelics for the management of treatment resistant conditions.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Evaluate the role of psychedelic agents for the management of mood and anxiety disorders

Financial Support

Supported by CME Outfitters

Target Audience

Physicians, physician assistants, nurse practitioners, nurses, and pharmacists

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to PAs: PAs may claim a maximum of .25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .25 contact hours (0.025 CEUs) Universal Activity Number:
Enduring: 0376-0000-20-098-H01-P

Type: knowledge-based

Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.cmeoutfitters.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Summergrad reports that he is on the advisory committee for Compass Pathways; Mental Health Data Services, Inc.; and Pear Therapeutics, Inc. He is a consultant for Compass Pathways; Cowen Inc; Mental Health Data Services, Inc.; and Pear Therapeutics, Inc. He is a stock shareholder (directly purchased) for Karuna Therapeutics; and Quartet Health, Inc. He receives other financial or material support (stock options) from Mental Health Data Services, Inc.; and Pear Therapeutics, Inc..

Howard Bliwise, MD (peer reviewer) has no disclosures to report.

Mae Ochoa, RPh (peer reviewer) has no disclosures to report.

Evan Luberger (planning committee) has no disclosures to report.

Jan Perez (planning committee) has no disclosures to report.

Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


This document was last modified on:

PD-025-050820-00